Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis-Reference-Cited by-同舟云学术

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

Published:2017-09 Issue:9 Volume:7 Page:e607-e607
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Haddox C L,Mangaonkar A A,Chen D,Shi M,He R,Oliveira J L,Litzow M R,Al-Kali A^ORCID,Hogan W J,Elliott M A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201789.pdf

Reference12 articles.

1. Stass S, Mirro J, Melvin S, Pui CH, Murphy SB, Williams D . Lineage switch in acute leukemia. Blood 1984; 64: 701–706.

2. Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M et al. The MLL recombinome of acute leukemias in 2013. Leukemia 2013; 27: 2165–2176.

3. Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med 2012; 366: 1371–1381.

4. Marchesi F, Girardi K, Avvisati G . Pathogenetic, clinical, and prognostic features of adult t(4;11)(q21;q23)/MLL-AF4 positive B-cell acute lymphoblastic leukemia. Adv Hematol 2011; 2011: 621627.

5. Hoffmann P, Hofmeister R, Brischwein K, Brandl C, Crommer S, Bargou R et al. Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct. Int J Cancer 2005; 115: 98–104.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community;Leukemia;2024-08-23

2. Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL;Blood;2024-07-04

3. Treatment of Relapsed Acute Lymphocytic Leukemia in Adult Patients;Current Treatment Options in Oncology;2024-06-25

4. Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia;Leukemia & Lymphoma;2024-05-22

5. A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience;Frontiers in Oncology;2024-05-21